The Highwire with Del Bigtree - WHAT IS THE TROUBLE WITH THE MONKEYPOX VACCINE?

Episode Date: October 18, 2022

Epidemiologist and cardiologist, Dr. Peter McCullough, explains the serious issues with the JYNNEOS vaccine used for Monkeypox.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.

But shockingly, when the Monkey Pox story started to evolve, we heard a report that the U.S. government had actually purchased 13 million doses of the Genios vaccine. The Genios vaccine. So wait a minute. The genios vaccine was coming along in 2018, 2019. And in fact, this is a live attenuated vaccine. And with it, in a study of over 3,003 people in the package insert. You know what the trouble is?

Myocarditis or heart inflammation. And now there's already reports of heart inflammation with this vaccine. Kieneth and colleagues reported in 2018 heart damage with the product in a young man age 36. Now the interesting thing is clinically, though, the people who are at risk for dying are young individuals with HIV. We can't use live attenuated viruses in people with HIV because they're immunocompromise. We have 13 million of these vaccines, and you're saying the known side effects, and the numbers are fairly high, right, in the trials of this vaccine, they had pretty high issues of myocarditis, and then, I believe, troponin levels. Is that correct?

Right. So up to 18 percent had elevations in cardiac tropon, and this is worrisome for subclinical myocarditis. We know that the smallpox virus itself has some tropism for the heart. And so the last thing we want to do, introduce. is a live attenuated virus that in fact would cause heart damage in ostensibly well people. There have already been case reports proving this with MRI and other clinical sources of data.